AXOVANT GENE THERAPIES LTD

CUSIP: G0750W203 Class: COM

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q3 2020
Shares 34,000 Value ($000) $157 Avg Close — Range —
Q2 2020
Shares 17,900 Value ($000) $50 Avg Close — Range —